Summit Rock Advisors, LP
- SEC CIK
- 0001540951
- Latest filing
- Aug 4, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 13, 2021. Long positions only.
- Positions
- 7
- No 13F data for Q4 2020
- Portfolio value
- $294.4M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Vanguard Total World Stock ETF922042742 | ETF | 1,369,410 | $133.2M | 45.3% | – | – | – |
| iShares Core S&P US Value ETF464287663 | ETF | 740,195 | $51.0M | 17.3% | – | – | – |
| Vanguard Ftse All-World Ex-US Small-Cap ETF922042718 | ETF | 338,612 | $43.5M | 14.8% | – | – | – |
| iShares Russell 2000 ETF464287655 | ETF | 152,585 | $33.7M | 11.5% | – | – | – |
| Vanguard Morningstar Value ETF922908744 | ETF | 237,808 | $31.3M | 10.6% | – | – | – |
| PHATPhathom Pharmaceuticals, Inc. | COM | 34,100 | $1.28M | 0.4% | – | – | History |
| FROGJFrog Ltd | Stock | 10,079 | $447.0K | 0.2% | – | – | History |